Andere talen BL Pharmtech Corp.

Aandelen

A065170

KR7065170003

slotkoers Korea S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
494 ^KRW	+1,02%		+6,47%	-2,18%

28/03	Youngchul Park heeft de overname afgerond van 24,43% belang in BL Pharmtech Corp. (KOSDAQ : A065170) van Bioleaders Corporation (KOSDAQ:A142760).	CI
20/03	BL Pharmtech Corp. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.	28/03
BL Pharmtech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Youngchul Park agreed to acquire 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation for KRW 9.3 billion.	12/03
BL Pharmtech agreed to acquire an additional 30.89% stake in Anyone F&C Co., Ltd. for KRW 9 billion	15/02
Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire a 58.73% stake in BL Healthcare Corp. from BL Healthcare Corp. for KRW 30 billion	29/12
BL Pharmtech Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
BL Pharmtech Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-08-23
BL Pharmtech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
Next Bt Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11-11-22
Next Bt Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13-05-22
Next Bt Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-22
Next Bt Co., Ltd. announced that it has received KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors	01-12-21
Next Bt Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors	29-11-21
Next Bt Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12-11-21
Next Bt Co., Ltd. announced that it has received KRW 10.4 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Securities Co., Ltd.	31-03-21
Next Bt Co., Ltd. announced that it expects to receive KRW 10.4 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Securities Co., Ltd.	29-03-21
Next Bt Co., Ltd. completed the acquisition of the remaining 77.7% stake in TCM Biosciences Inc..	17-07-20
Next Bt Co., Ltd. agreed to acquire the remaining 77.7% stake in TCM Biosciences Inc. for KRW 37 billion.	20-04-20
Next Bt Co., Ltd. acquired 22.25% stake in TCM Biosciences Inc. from Park Young Chul for KRW 15.9 billion.	31-03-20
Next Bt Co., Ltd. announced that it has received KRW 6.5 billion in funding	07-01-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BL Pharmtech Corp.

Aandelen

A065170

KR7065170003

Andere talen

Filters